Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA 403 Forbidden page is now shown, with a basic header including Home and Revision: v3.7.0; at the same time, a large set of study documents and content (e.g., SAP, IPD sharing, ICF, PDFs, and location data) was removed from the study record.SummaryDifference21%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAn NIH grant/contract reference for 2019 was added under Other Study IDs, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page displays a new revision stamp of v3.6.5, replacing the previous v3.6.4. This indicates a small maintenance update to the page rather than a change to study details or user actions.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing the previous Revision: v3.6.3. This appears to be a small metadata update to the page version rather than a change to the study content.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.6.3 is now shown, replacing the previous v3.6.2. This reflects a small, backend/maintenance update to the page.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.6.2 is now shown on the page, replacing the previous v3.6.0. This indicates the page content has been updated to a newer version.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.